Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis

Journal of Crohn's and Colitis

Volumn 4, Issue 6, 2010, Pages 683-686

  Van Hauwaert, Valérie ^a   Meers, Stef ^a   Verhoef, Gregor ^a   Vermeire, Séverine ^a   Rutgeerts, Paul ^a   Van Assche, Gert ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Infliximab; Non Hodgkin's lymphoma; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INFLIXIMAB; INTERFERON REGULATORY FACTOR 4; LACTATE DEHYDROGENASE; MESALAZINE; PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN GCET 1; STEROID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE EXACERBATION; ENDOSCOPY; ENTERITIS; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MALE; METAPHASE; NONHODGKIN LYMPHOMA; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECTUM BIOPSY; RECTUM CARCINOMA; RECTUM MUCOSA; REMISSION; SUBMUCOSA; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BIOPSY; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLONOSCOPY; GASTROINTESTINAL AGENTS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; RECTAL NEOPLASMS; YOUNG ADULT;

EID: 78649498397     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.06.006     Document Type: Article

References (31)

1. Tilly H, Dreyling M. ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May;20 Suppl 4:110-2. Erratum in: Ann Oncol. 2009 Sep;20(9):1612.
2. Biancone L., Michetti P., Travis S. European evidence-based consensus on the management of ulcerative colitis: special situations. J Cron's colitis 2008, 2:63-92.
3. Lewis J.D., Bilker W.B., Brensinger C., Deren J.J., Vaughn D.J., Strom B.L. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001, 121:1080-1087.
4. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91:854-862.
5. Baecklund E., Ekbom A., Sparén P., Feltelius N., Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. Br Med J 1998, 317:180-181.
6. Baecklund E., Iliadou A., Askling J., Ekbom A., Backlin C., Granath F., et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arth Rheum 2006, 54:692-701.
7. Siegel C., Marden S.M., Persing S.M., Larson J.R., Sands B.E. Risk of lymphoma associated with anti-TNF agents for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol 2009, 7:874-881.
8. Kandiel A., Fraser A.G., Korelitz B.I., Brensinger C., Lewis J.D. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005, 54:1121-1125.
9. Palli D., Trallori G., Bagnoli S., Saieva C., Tarantino O., Ceroti M., et al. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000, 119:647-653.
10. Fidder H., Schnitzler F., Ferrante M., Noman M., Katsanos K., Segaert S., et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single centre cohort study. Gut Apr 2009, 58(4):501-508.
11. Mackey A.C., Green L., Leptak C., et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. J Pediatr Gastroenterol Nutr 2009, 48:386-388.
12. Mackey A.C., Green L., Liang L.C., Dinndorf P., Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007, 44:265-267.
13. Rosh J.R., Gross T., Mamula P., Griffiths A., Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?. Inflamm Bowel Dis 2007, 13:1024-1030.
14. Mittal S., Milner B.J., Johnston P.W., Culligan D.J. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur J Haematol 2006, 76:531-534.
15. Beaugerie L., Brousse N., Bouvier A.M., Colombel J.F., Lémann M., Cosnes J., et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet Nov 7 2009, 374(9701):1617-1625.
16. Dayharsh G.A., Loftus E.V., Sandborn W.J., Tremaine W.J., Zinsmeister A.R., Witzig T.E., et al. Epstein-Barr positive lyphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 2002, 122:72-77.
17. Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis. Dig and Liv dis 2010. Webpublished.
18. Ekström-Smedby K. Epidemiologhy and etiology of non-Hodgkin lymphoma-a review. Acta Oncol 2006, 45:258-271.
19. Ekström-Smedby K., Vajdic C.M., Falster M., Engels E.A., Martínez-Maza O., Turner J., et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood Apr 15 2008, 111(8):4029-4038.
20. Zintzaras E., Voulgarelis M., Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med Nov 14 2005, 165(20):2337-2344.
21. Cholongita E., Chrysoula P., Kaklamanis L., Dasenaki M. Is there any association between non-Hodgkin's lymphoma and primary sclerosing cholangitis/autoimmune hepatitis overlap syndrome?. Dig Dis Sci 2008, 53:867-868.
22. Radice E., Nelson H., Devine R.M., Dozois R.R., Nivatvongs S., Pemberton J.H., et al. Ileal pouch-anal anastomosis in patients with colorectal cancer: long-term functional and oncologic outcomes. Dis Colon Rectum Jan 1998, 41(1):11-17.
23. Zmora O., Spector D., Dotan I., Klausner J.M., Rabau M., Tulchinsky H. Is stapled ileal pouch anal anastomosis a safe option in ulcerative colitis patients with dysplasia or cancer?. Int J Colorectal Dis Oct 2009, 24(10):1181-1186. Electronic publication 2009 Jun 2.
24. Parc Y., Zutshi M., Zalinski S., Ruppert R., Fürst A., Fazio V.W. Preoperative radiotherapy is associated with worse functional results after coloanal anastomosis for rectal cancer. Dis Colon Rectum 2009, 52:2004-2015.
25. Penna C., Dozois R., Tremaine W., Sandborn W., LaRusso N., Schleck C., et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996, 38:234-239.
26. Lepistö A., Kärkkäinen P., Järvinen H.J. Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 2008, 14:775-779.
27. Ferrante M., Declerck S., De Hertogh G., Van Assche G., Geboes K., Rutgeerts P., et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis. Inflamm Bowel Dis 2008, 14:20-28.
28. Gorgun E., Remzi F.H., Manilich E., Preen M., Shen B., Fazio V.W. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Surgery 2005, 128:631-639.
29. Mathis K.L., Dozois E.J., Larson D.W., Cima R.R., Sarmiento J.M., Wolff B.G., et al. Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg Jul 2008, 95(7):882-886.
30. Cho C.S., Dayton M.T., Thompson J.S., Koltun W.A., Heise C.P., Harms B.A. Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis. J Gastrointest Surg Jul 2008, 12(7):1221-1226. Electronic publication 2008 May 1.
31. Grucela A.L., Steinhagen R.M. Restorative proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis after liver transplant for primary sclerosing cholangitis: case report and review of literature. Am Surg Apr 2005, 71(4):362-365.